Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

被引:522
作者
Bluemn, Eric G. [1 ,2 ]
Coleman, Ilsa M. [2 ]
Lucas, Jared M. [2 ]
Coleman, Roger T. [2 ]
Hernandez-Lopez, Susana [2 ]
Tharakan, Robin [2 ]
Bianchi-Frias, Daniella [2 ]
Dumpit, Ruth F. [2 ]
Kaipainen, Arja [2 ]
Corella, Alexandra N. [2 ]
Yang, Yu Chi [2 ]
Nyquist, Michael D. [2 ]
Mostaghel, Elahe [1 ,2 ]
Hsieh, Andrew C. [1 ,2 ]
Zhang, Xiaotun [3 ]
Corey, Eva [3 ]
Brown, Lisha G. [3 ]
Nguyen, Holly M. [3 ]
Pienta, Kenneth [6 ]
Ittmann, Michael [1 ,7 ]
Schweizer, Michael
True, Lawrence D. [4 ]
Wise, David [5 ]
Rennie, Paul S. [8 ]
Vessella, Robert L. [3 ]
Morrissey, Colm [3 ]
Nelson, Peter S. [1 ,2 ,3 ,4 ]
机构
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Div Human Biol & Clin Res, Mailstop D4-100,1100 Fairview Ave N, Seattle, WA 98109 USA
[3] Univ Washington, Dept Urol, 1959 NE Pacific St, Seattle, WA 98195 USA
[4] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Johns Hopkins Univ, Baltimore, MD USA
[7] Baylor Coll Med, Houston, TX 77030 USA
[8] Vancouver Prostate Ctr, Vancouver, BC, Canada
关键词
SMALL-CELL CARCINOMA; LINEAGE PLASTICITY; INCREASED SURVIVAL; MOUSE MODEL; IN-VIVO; ACTIVATION; IDENTIFICATION; METASTASIS; RESISTANCE; EXPRESSION;
D O I
10.1016/j.ccell.2017.09.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Androgen receptor (AR) signaling is a distinctive feature of prostate carcinoma (PC) and represents the major therapeutic target for treating metastatic prostate cancer (mPC). Though highly effective, AR antagonism can produce tumors that bypass a functional requirement for AR, often through neuroendocrine (NE) transdifferentiation. Through the molecular assessment of mPCs over two decades, we find a phenotypic shift has occurred in mPC with the emergence of an AR-null NE-null phenotype. These "double-negative'' PCs are notable for elevated FGF and MAPK pathway activity, which can bypass AR dependence. Pharmacological inhibitors of MAPK or FGFR repressed the growth of double-negative PCs in vitro and in vivo. Our results indicate that FGF/MAPK blockade may be particularly efficacious against mPCs with an AR-null phenotype.
引用
收藏
页码:474 / +
页数:22
相关论文
共 64 条
[1]   Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition [J].
Acevedo, Victor D. ;
Gangula, Rama D. ;
Freeman, Kevin W. ;
Li, Rile ;
Zhang, Youngyou ;
Wang, Fen ;
Ayala, Gustavo E. ;
Peterson, Leif E. ;
Ittmann, Michael ;
Spencer, David M. .
CANCER CELL, 2007, 12 (06) :559-571
[2]   PROSTATE-SPECIFIC ANTIGEN AND GLEASON GRADE - AN IMMUNOHISTOCHEMICAL STUDY OF PROSTATE-CANCER [J].
AIHARA, M ;
LEBOVITZ, RM ;
WHEELER, TM ;
KINNER, BM ;
OHORI, M ;
SCARDINO, PT .
JOURNAL OF UROLOGY, 1994, 151 (06) :1558-1564
[3]   Neuroendocrine Prostate Cancer Xenografts With Large-Cell and Small-Cell Features Derived From a Single Patient's Tumor: Morphological, Immunohistochemical, and Gene Expression Profiles [J].
Aparicio, Ana ;
Tzelepi, Vasiliki ;
Araujo, John C. ;
Guo, Charles C. ;
Liang, Shoudan ;
Troncoso, Patricia ;
Logothetis, Christopher J. ;
Navone, Nora M. ;
Maity, Sankar N. .
PROSTATE, 2011, 71 (08) :846-856
[4]   Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade [J].
Arora, Vivek K. ;
Schenkein, Emily ;
Murali, Rajmohan ;
Subudhi, Sumit K. ;
Wongvipat, John ;
Balbas, Minna D. ;
Shah, Neel ;
Cai, Ling ;
Efstathiou, Eleni ;
Logothetis, Chris ;
Zheng, Deyou ;
Sawyers, Charles L. .
CELL, 2013, 155 (06) :1309-1322
[5]   ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer [J].
Aytes, Alvaro ;
Mitrofanova, Antonina ;
Kinkade, Carolyn Waugh ;
Lefebvre, Celine ;
Lei, Ming ;
Phelan, Vanessa ;
LeKaye, H. Carl ;
Koutcher, Jason A. ;
Cardiff, Robert D. ;
Califano, Andrea ;
Shen, Michael M. ;
Abate-Shen, Cory .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (37) :E3506-E3515
[6]   Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer [J].
Beltran, Himisha ;
Prandi, Davide ;
Mosquera, Juan Miguel ;
Benelli, Matteo ;
Puca, Loredana ;
Cyrta, Joanna ;
Marotz, Clarisse ;
Giannopoulou, Eugenia ;
Chakravarthi, Balabhadrapatruni V. S. K. ;
Varambally, Sooryanarayana ;
Tomlins, Scott A. ;
Nanus, David M. ;
Tagawa, Scott T. ;
Van Allen, Eliezer M. ;
Elemento, Olivier ;
Sboner, Andrea ;
Garraway, Levi A. ;
Rubin, Mark A. ;
Demichelis, Francesca .
NATURE MEDICINE, 2016, 22 (03) :298-305
[7]   Aggressive Variants of Castration-Resistant Prostate Cancer [J].
Beltran, Himisha ;
Tomlins, Scott ;
Aparicio, Ana ;
Arora, Vivek ;
Rickman, David ;
Ayala, Gustavo ;
Huang, Jiaoti ;
True, Lawrence ;
Gleave, Martin E. ;
Soule, Howard ;
Logothetis, Christopher ;
Rubin, Mark A. .
CLINICAL CANCER RESEARCH, 2014, 20 (11) :2846-2850
[8]   Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets [J].
Beltran, Himisha ;
Rickman, David S. ;
Park, Kyung ;
Chae, Sung Suk ;
Sboner, Andrea ;
MacDonald, Theresa Y. ;
Wang, Yuwei ;
Sheikh, Karen L. ;
Terry, Stephane ;
Tagawa, Scott T. ;
Dhir, Rajiv ;
Nelson, Joel B. ;
de la Taille, Alexandre ;
Allory, Yves ;
Gerstein, Mark B. ;
Perner, Sven ;
Pienta, Kenneth J. ;
Chinnaiyan, Arul M. ;
Wang, Yuzhuo ;
Collins, Colin C. ;
Gleave, Martin E. ;
Demichelis, Francesca ;
Nanus, David M. ;
Rubin, Mark A. .
CANCER DISCOVERY, 2011, 1 (06) :487-495
[9]   Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer [J].
Carver, Brett S. ;
Chapinski, Caren ;
Wongvipat, John ;
Hieronymus, Haley ;
Chen, Yu ;
Chandarlapaty, Sarat ;
Arora, Vivek K. ;
Le, Carl ;
Koutcher, Jason ;
Scher, Howard ;
Scardino, Peter T. ;
Rosen, Neal ;
Sawyers, Charles L. .
CANCER CELL, 2011, 19 (05) :575-586
[10]   Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression [J].
Cheng, Helen ;
Snoek, Rob ;
Ghaidi, Fariba ;
Cox, Michael E. ;
Rennie, Paul S. .
CANCER RESEARCH, 2006, 66 (21) :10613-10620